AU2966297A - Alpha blockers (e.g. moxisylyte and/or derivatives thereof) for treating erectile dysfunction - Google Patents
Alpha blockers (e.g. moxisylyte and/or derivatives thereof) for treating erectile dysfunctionInfo
- Publication number
- AU2966297A AU2966297A AU29662/97A AU2966297A AU2966297A AU 2966297 A AU2966297 A AU 2966297A AU 29662/97 A AU29662/97 A AU 29662/97A AU 2966297 A AU2966297 A AU 2966297A AU 2966297 A AU2966297 A AU 2966297A
- Authority
- AU
- Australia
- Prior art keywords
- moxisylyte
- derivatives
- erectile dysfunction
- treating erectile
- alpha blockers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000010228 Erectile Dysfunction Diseases 0.000 title 1
- VRYMTAVOXVTQEF-UHFFFAOYSA-N acetic acid [4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] ester Chemical compound CC(C)C1=CC(OC(C)=O)=C(C)C=C1OCCN(C)C VRYMTAVOXVTQEF-UHFFFAOYSA-N 0.000 title 1
- 239000002160 alpha blocker Substances 0.000 title 1
- 229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 title 1
- 201000001881 impotence Diseases 0.000 title 1
- 229960003509 moxisylyte Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/41—Devices for promoting penis erection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nursing (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9606105 | 1996-05-15 | ||
| FR9606105A FR2748658B1 (en) | 1996-05-15 | 1996-05-15 | USE OF "ALPHA-BLOCKING" COMPOUNDS, PARTICULARLY MOXISYLYTE AND / OR DERIVATIVES THEREOF FOR THE TREATMENT OF ERECTILE DYSFUNCTIONS BY BALAN TRANSMUCOSAL ROUTE |
| PCT/FR1997/000837 WO1997042946A1 (en) | 1996-05-15 | 1997-05-13 | ALPHA BLOCKERS (e.g. MOXISYLYTE AND/OR DERIVATIVES THEREOF) FOR TREATING ERECTILE DYSFUNCTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2966297A true AU2966297A (en) | 1997-12-05 |
Family
ID=9492189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU29662/97A Abandoned AU2966297A (en) | 1996-05-15 | 1997-05-13 | Alpha blockers (e.g. moxisylyte and/or derivatives thereof) for treating erectile dysfunction |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0906093A1 (en) |
| CN (1) | CN1225581A (en) |
| AU (1) | AU2966297A (en) |
| FR (1) | FR2748658B1 (en) |
| TR (1) | TR199802324T2 (en) |
| WO (1) | WO1997042946A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6469065B1 (en) | 1996-02-02 | 2002-10-22 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use |
| US7087240B1 (en) | 1998-06-25 | 2006-08-08 | Lavipharm Laboratories Inc. | Device and method for the treatment of erectile dysfunction |
| DE69927154T2 (en) * | 1998-06-25 | 2006-06-29 | Lavipharm Laboratories, Inc. | DEVICE AND METHOD FOR TREATING EFFECTIVE ERRORS |
| WO2018073821A1 (en) * | 2016-10-18 | 2018-04-26 | Vasolead (2012) Ltd. | Compositions and methods for treating erectile dysfunction |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801587A (en) * | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
| US5256652A (en) * | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
| FR2666507A1 (en) * | 1990-09-07 | 1992-03-13 | Sarget Lab | Pharmaceutical compositions for the topical administration of moxisylyte and of deacetylmoxisylyte and their uses in therapy |
| BR9203277A (en) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | USE OF ERETOGENIC DRUGS AND THEIR APPLICATION METHODOLOGIES |
| US5565466A (en) * | 1993-08-13 | 1996-10-15 | Zonagen, Inc. | Methods for modulating the human sexual response |
| US5741511A (en) * | 1995-04-12 | 1998-04-21 | Sam Yang Co., Ltd. | Transdermal drug delivery device for treating erectile dysfunction |
-
1996
- 1996-05-15 FR FR9606105A patent/FR2748658B1/en not_active Expired - Fee Related
-
1997
- 1997-05-13 AU AU29662/97A patent/AU2966297A/en not_active Abandoned
- 1997-05-13 TR TR1998/02324T patent/TR199802324T2/en unknown
- 1997-05-13 CN CN 97196485 patent/CN1225581A/en active Pending
- 1997-05-13 WO PCT/FR1997/000837 patent/WO1997042946A1/en not_active Ceased
- 1997-05-13 EP EP97924075A patent/EP0906093A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| FR2748658A1 (en) | 1997-11-21 |
| WO1997042946A1 (en) | 1997-11-20 |
| FR2748658B1 (en) | 2000-08-18 |
| EP0906093A1 (en) | 1999-04-07 |
| TR199802324T2 (en) | 2001-01-22 |
| CN1225581A (en) | 1999-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA971259B (en) | Antimicrobial peptides and methods of use. | |
| AU2440997A (en) | Calixpyrroles, calixpyridinopyrroles and calixpyridines | |
| GB2319515B (en) | Corkscrew | |
| SG65015A1 (en) | Substrate treatment system | |
| AU5358896A (en) | Method and kit for preventing erectile dysfunction | |
| GB9608408D0 (en) | Treatment of erectile dysfunction | |
| ZA976222B (en) | N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use. | |
| ZA973708B (en) | Benzofuryl derivatives and their use. | |
| ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
| ZA978323B (en) | Operation of airports. | |
| ZA979151B (en) | Pyrazolinones for treating impaired potency. | |
| AU1074299A (en) | Methods and kits for removing, treating or preventing lice | |
| AU2966297A (en) | Alpha blockers (e.g. moxisylyte and/or derivatives thereof) for treating erectile dysfunction | |
| AU4178497A (en) | HTm4, methods of treatment and assays, agonists and antagonists | |
| ZA972728B (en) | Apparatus and procedure for minimizing the risks of inhalative no-therapy. | |
| ZA977791B (en) | GLP-1 derivatives. | |
| ZA971217B (en) | Diamond treatment. | |
| ZA9710318B (en) | Safe re-locker. | |
| ZA9711047B (en) | Formulation and use. | |
| ZA971167B (en) | Heterocyclyl-ergoline derivatives. | |
| AU8998898A (en) | Sludge or excreta treating agent, treating method, and treating apparatus | |
| PL331283A1 (en) | Preparation for treating and/or preventing stupefaction | |
| AUPN808296A0 (en) | Bauxite treatment | |
| GB9613860D0 (en) | Topical preparation or erectile dysfunction | |
| ZA979541B (en) | Pretraumatic use of hemoglobin. |